Comparison of the Safety and Tolerance Profile of Micafungin with that of Other Echinocandins and Azoles in Patients with Pre-existing Child–Pugh B or C Liver Disease: A Case–Control Retrospective Study
Abstract Introduction To assess the association between exposure to micafungin, other echinocandins, or azoles and the development of short-term liver injury (STLI) or long-term liver injury (LTLI) in patients with Child–Pugh B or C liver disease. Methods Multicenter case–control study of patients w...
Main Authors: | Antonio Vena, Emilio Bouza, Matteo Bassetti, Francesco Menichetti, Maria Merelli, Santiago Grau, Jesús Fortun, María Isabel Sánchez, José María Aguado, Paloma Merino, Francisco Bonache, Patricia Muñoz |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-02-01
|
Series: | Infectious Diseases and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40121-020-00282-w |
Similar Items
-
Are we near to the end of the standard dose of micafungin?
by: Alexander Agrifoglio, et al.
Published: (2018-06-01) -
Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin
by: Fazal Shirazi, et al.
Published: (2015-10-01) -
A case of Candida glabrata severe urinary sepsis successfully treated with micafungin
by: Filippo Pieralli, et al.
Published: (2014-07-01) -
Effectiveness and Safety of Micafungin in Managing Invasive Fungal Infections among Patients in Greece with Hematologic Disorders: The ASPIRE Study
by: Maria Kotsopoulou, et al.
Published: (2019-02-01) -
A case of immune complex type hemolytic anemia induced by initial micafungin administration
by: Hiroto Ishii, et al.
Published: (2022-09-01)